|
Sign In to gain access to subscriptions and/or personal tools.
|
Commentary: Microalbuminuria — the next target for vascular disease prevention?
Behdad Afzali
James E Marsh
Renal Unit, St Helier Hospital, Epsom and St Helier University Hospitals, Wrythe Lane, Carshalton, SM5 1AA, UK, james.marsh{at}epsom-sthelier.nhs.uk
References
- Gerstein HC, Mann JF, Yi Q. et al. Albuminuria and risk of cardiovascular events, deaths and heart failure in diabetic and non-diabetic individuals. JAMA 2001;286:421-6.[Abstract/Free Full Text]
- Wachtell K., Ibsen H., Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE trial. Ann Intern Med 2003;139:901-06.[Abstract/Free Full Text]
- Hillege HL, Fidler V., Diercks GF et al. Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation 2002;106:1777-82.[Abstract/Free Full Text]
- Roest M., Banga JD, Janssen WM et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 2001;103:3057-61.[Abstract/Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 6,
342-343 (2005)
DOI: 10.1177/14746514050050060801

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|